Acknowledgement
Supported by : KAIST
References
- Goldberg M, Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Disc. 2003;2:289-95. https://doi.org/10.1038/nrd1067
- Charman WNA, Stella VJ. Estimating the maximum potential for intestinal lymphatic transport of lipophilic drug molecules. Int J Pharm. 1986;34:175-8. https://doi.org/10.1016/0378-5173(86)90027-X
- Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Disc. 2007;6: 231-48. https://doi.org/10.1038/nrd2197
- Ali Khan A, Mudassir J, Mohtar N, Darwis Y. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomedicine. 2013;8: 2733-44.
- Wasan KM, et al. Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. Nat Rev Drug Disc. 2008;7:84-99. https://doi.org/10.1038/nrd2353
- Trevaskis NL, et al. From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Disc. 2015;14:781-803. https://doi.org/10.1038/nrd4608
- Shi Y, Burn P. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Disc. 2004;3:695-710. https://doi.org/10.1038/nrd1469
- Porter CJH, et al. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 2001;50:61-80. https://doi.org/10.1016/S0169-409X(01)00151-X
- Redgrave TG. Chylomicron metabolism. Biochem Soc Trans. 2004;32:79-82. https://doi.org/10.1042/bst0320079
- Khoo S-M, et al. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine. J Pharm Sci. 2001;90:1599-607. https://doi.org/10.1002/jps.1110
- Murakami M, et al. Enteral siRNA delivery technique for therapeutic gene silencing in the liver via the lymphatic route. Sci Rep. 2015;5:1-13.
- Zhou C, et al. The preparation of a complex of insulin-phospholipids and their interaction mechanism. J Pept Sci. 2012;18:541-8. https://doi.org/10.1002/psc.2423
- Fricker G, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharma Res. 2010;27:1469-86. https://doi.org/10.1007/s11095-010-0130-x
- Charman WN. Lipids, lipophilic drugs, and oral drug delivery-Some emerging concepts. J Pharm Sci. 2000;89:967-78. https://doi.org/10.1002/1520-6017(200008)89:8<967::AID-JPS1>3.0.CO;2-R
- Dahan A, et al. The oral absorption of phospholipid prodrugs: In vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration. J Control Release. 2008;126:1-9. https://doi.org/10.1016/j.jconrel.2007.10.025
- Khan MSY, Akhter M. Glyceride derivatives as potential prodrugs: synthesis, biological activit y and kinetic studies of glyceride derivatives of mefenamic acid. Pharmazie. 2005;60:110-4.
- Caliph SM, et al. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymphcannulated and non-cannulated rats. J Pharm Sci. 2000;89:1073-84. https://doi.org/10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V
- Attili-Qadri S, et al. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption. Proc Natl Acad Sci U S A. 2013;110:17498-503. https://doi.org/10.1073/pnas.1313839110
- Fang G, et al. Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies. RSC Adv. 2015;5:437-96447.
- Paliwal R, et al. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. J Pharm. 2009;29:181-8.
- Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Disc. 2005;5:145-60.
- Yoo J-W, et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Disc. 2011;10:521-35. https://doi.org/10.1038/nrd3499
- Allen TM, Cullis PR. Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev. 2013;65:36-48. https://doi.org/10.1016/j.addr.2012.09.037
- Andar AU, et al. Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms. Pharm Res. 2014;31:401-13. https://doi.org/10.1007/s11095-013-1171-8
- Kim H, et al. Liposomal formulations for enhanced lymphatic drug delivery. Asian J Pharm Sci. 2013;8:96-103. https://doi.org/10.1016/j.ajps.2013.07.012
- Iwanaga K, et al. Oral delivery of insulin by using surface coating liposomes: Improvement of stability of insulin in GI tract. Int J Pharm. 1997;157:73-80. https://doi.org/10.1016/S0378-5173(97)00237-8
- Kisel MA, et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int J Pharm. 2001;216:105-14. https://doi.org/10.1016/S0378-5173(01)00579-8
- Ling SSN, et al. Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Dev Ind Pharm. 2006; 32:335-45. https://doi.org/10.1080/03639040500519102
- Niu M, et al. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: The effect of cholate type, particle size and administered dose. Eur J Pharm Biopharm. 2012;81:265-72. https://doi.org/10.1016/j.ejpb.2012.02.009
- Niu M, et al. Enhanced oral absorption of insulin-loaded liposomes containing bile salts: A mechanistic study. Int J Pharm. 2014;460:119-30. https://doi.org/10.1016/j.ijpharm.2013.11.028
- Huang Y-B, et al. Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. J Drug Target. 2011;19:709-18. https://doi.org/10.3109/1061186X.2010.551402
- Li X, et al. Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake. Int J Nanomedicine. 2011;6:3151-62.
- Takeuchi H, et al. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release. 2003;86:235-42. https://doi.org/10.1016/S0168-3659(02)00411-X
- Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev. 2001;52:117-26. https://doi.org/10.1016/S0169-409X(01)00231-9
- Takeuchi H, et al. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res. 1996;13:896-901. https://doi.org/10.1023/A:1016009313548
- Kim HJ, Lee CM, Lee YB, et al. Preparation and mucoadhesive test of CSAloaded liposomes with different characteristics for the intestinal lymphatic delivery. Biotechnol Bioprocess Eng. 2005;10:516-21. https://doi.org/10.1007/BF02932287
Cited by
- Update December 2016 vol.14, pp.4, 2016, https://doi.org/10.1089/lrb.2016.29016.fb
- Absorption, metabolism, distribution and faecal excretion of B-type procyanidin oligomers in mice after a single oral administration of black soybean seed coat extract vol.9, pp.10, 2016, https://doi.org/10.1039/c8fo00852c
- Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs vol.15, pp.8, 2018, https://doi.org/10.1080/17425247.2018.1503249
- Biodistribution of Liposome-Encapsulated Bacteriophages and Their Transcytosis During Oral Phage Therapy vol.10, pp.None, 2016, https://doi.org/10.3389/fmicb.2019.00689
- Lymphatic Vasculature in Energy Homeostasis and Obesity vol.11, pp.None, 2016, https://doi.org/10.3389/fphys.2020.00003
- The Current Landscape of Novel Formulations and the Role of Mathematical Modeling in Their Development vol.60, pp.suppl1, 2016, https://doi.org/10.1002/jcph.1715
- Poloxamer-188 and D -α-Tocopheryl Polyethylene Glycol Succinate (TPGS-1000) Mixed Micelles Integrated Orodispersible Sublingual Films to Improve Oral Bioavailability of Ebastine; vol.13, pp.1, 2016, https://doi.org/10.3390/pharmaceutics13010054
- Advances in Oral Drug Delivery vol.12, pp.None, 2016, https://doi.org/10.3389/fphar.2021.618411
- Automated PET-RAFT Polymerization toward Pharmaceutical Amorphous Solid Dispersion Development vol.3, pp.3, 2021, https://doi.org/10.1021/acsapm.0c01376
- Recent Advancements in Polymer/Liposome Assembly for Drug Delivery: From Surface Modifications to Hybrid Vesicles vol.13, pp.7, 2021, https://doi.org/10.3390/polym13071027
- Comparison of nanoparticle-selenium, selenium-enriched yeast and sodium selenite on the alleviation of cadmium-induced inflammation via NF-kB/IκB pathway in heart vol.773, pp.None, 2016, https://doi.org/10.1016/j.scitotenv.2021.145442
- Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances vol.9, pp.24, 2016, https://doi.org/10.1039/d1tb00126d
- Engineering Nano‐ and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport vol.33, pp.51, 2016, https://doi.org/10.1002/adma.202104139
- Lymphatic transport system to circumvent hepatic metabolism for oral delivery of lipid-based nanocarriers vol.66, pp.None, 2016, https://doi.org/10.1016/j.jddst.2021.102934